Zefia Uppal

PHD Doctor of Philosophy,  CharitĂ© - Universitätsmedizin Berlin 

Location: Germany

Consulting Services

Grant Submission Research Consulting Admin and Customer Support

Areas Of Interest

Lipoprotein VLDL II Fibrosarcomatous Dermatofibrosarcoma Protuberan Dyssomnia Polyomavirus Small T Antigens Magna, Cisterna Cystorelin Mussels, Native Cortex Cerebri Oxonic Acid Spinner Dolphins Deficiency Disease, Betalipoprotein Manatees, Caribbean Phages, fd B-1 Lymphocyte Shingles Vaccine Cyamposis Inborn Metabolic Brain Diseases Osteolysis, Multicentric Postpartum Depression Dehydrogenase Antagonists, Acetaldehyde Lysolecithinase Aspirin-Like Agents Fat, Visceral Typing Techniques, Fungal Areas, Preoptico-Hypothalamic Enterovirus Infections Citrate, Norflex Orphenadrine

Professional Narrative

Dr. Zefia Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Director Medicine, Mayo Clinic 2010
Executive Director, Amgen 1994

Education

Bachelor of science in nursing, Perelman School of Medicine 1993
Doctor of medicine, Yale School of Medicine 1995

Referees


Publications

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :